β-Lactamase-IN-2
β-Lactamase-IN-2 is a beta-lactamase inhibitor, extracted from patent WO 2019075084 A1, compound 1. β-Lactamase-IN-2 has anti-microbial and anti-bacterial effects[1].
Product Specifications
CAS Number
[2114651-20-4]
Product Name Alternative
EX-A4764; UUN51204
UNSPSC
12352005
Target
Antibiotic; Bacterial; Beta-lactamase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/β-lactamase-in-2.html
Purity
98.59
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C(OC=C2)C2=CC=C1F)OCC
Molecular Formula
C11H9FO3
Molecular Weight
208.19
References & Citations
[1]Scott J. Hecker, et al. Boronic acid derivatives and synthesis thereof. Patent WO 2019075084
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
M9202-50 10 mg
Mubritinib, Free Base (1-[4-[4-[[2-[ (1E) -2-[4- (Trifluoromethyl) phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole, TAK-165, D04025)
Ask
View Details